REMICADE
Live / Registered — Registered and renewed (as of 23 Oct 2019)
What this means for you
Registered since 28 Mar 2000. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 28 Mar 2030: the §8 & §9 renewal).
Record
- Serial number
- 75516013
- Registration number
- 2336754
- Mark type
- Word mark
- Filed
- 09 Jul 1998
- Published for opposition
- 15 Jun 1999
- Registered
- 28 Mar 2000
- Current term from
- 28 Mar 2020
- Next maintenance filing
- §8 & §9 renewal, due by 28 Mar 2030 (grace period to 28 Sept 2030)
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions for treatment of autoimmune diseases and disorders
Owner
- JANSSEN BIOTECH, INC., HORSHAM, PA, US
- CENTOCOR ORTHO BIOTECH INC., HORSHAM, PA, US
- Centocor, Inc., Malvern, PA, US
- Centocor, Inc., Malvern, PA, US
- Centocor, Inc., Malvern, PA, US
Board proceedings on this mark
The owner also pleads this mark in 4 other Board proceedings.
Board decisions about this mark
Prosecution history
- 23 Oct 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Oct 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 23 Oct 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 23 Oct 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Sept 2019 — TEAS SECTION 8 & 9 RECEIVED
- 28 Mar 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Sept 2014 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Sept 2014 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 11 Apr 2012 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 27 Mar 2010 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 27 Mar 2010 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 26 Mar 2010 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 26 Mar 2010 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 27 Mar 2010 — REVIEW OF CORRESPONDENCE COMPLETE
- 26 Mar 2010 — TEAS SECTION 8 & 9 RECEIVED